Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Tokyo Women'S Medical University manages a patent portfolio in the Biotechnology & Pharmaceuticals technology area. There are currently 2 pending office actions across the portfolio. This indicates a moderate level of ongoing prosecution activity that requires the management of multiple active files.
The university's filings are distributed among 2 distinct examiners and 2 distinct art units. This spread suggests that the research being patented covers different technical sub-fields within the biotechnology sector. Navigating 2 distinct art units requires the university to adapt to different examiner expectations and procedural environments, which can increase the complexity of the prosecution strategy.
TAKENAKA, RISA is the busiest examiner for the university. This examiner is responsible for 1 pending office action. Since there are 2 pending office actions in total, this examiner handles a portion of the current workload, while the remaining action is managed by a different examiner in a separate art unit.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| TAKENAKA, RISA | 1 | 28.0% | +100.0% |
| TINSLEY, BRENDAN THOMAS | 1 | 59.6% | +73.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18573148 | METHOD FOR PRODUCING COMPOSITION FOR CULTURING ANIMAL CELLS, COMPOSITION FOR CULTURING ANIMAL CELLS OBTAINED BY SAID METHOD, AND METHOD FOR CULTURING ANIMAL CELLS USING SAID COMPOSITION FOR CULTURING ANIMAL CELLS | TAKENAKA, RISA | — |
| 18564864 | COMPOSITION FOR CULTURING ALGAE AND ALGAE CULTURING METHOD | TINSLEY, BRENDAN THOMAS | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18573148 | METHOD FOR PRODUCING COMPOSITION FOR CULTURING ANIMAL CELLS, COMPOSITION FOR CULTURING ANIMAL CELLS OBTAINED BY SAID METHOD, AND METHOD FOR CULTURING ANIMAL CELLS USING SAID COMPOSITION FOR CULTURING ANIMAL CELLS | TAKENAKA, RISA | — |
| 18564864 | COMPOSITION FOR CULTURING ALGAE AND ALGAE CULTURING METHOD | TINSLEY, BRENDAN THOMAS | — |
| Art Unit | Apps |
|---|---|
| 1632 | 1 |
| 1634 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18573148 | METHOD FOR PRODUCING COMPOSITION FOR CULTURING ANIMAL CELLS, COMPOSITION FOR CULTURING ANIMAL CELLS OBTAINED BY SAID METHOD, AND METHOD FOR CULTURING ANIMAL CELLS USING SAID COMPOSITION FOR CULTURING ANIMAL CELLS | TAKENAKA, RISA | 1632 | §103§112DP | Non-Final OA | — | Pending | Dec 21, 2023 |
| 18564864 | COMPOSITION FOR CULTURING ALGAE AND ALGAE CULTURING METHOD | TINSLEY, BRENDAN THOMAS | 1634 | §103§112Other | Non-Final OA | — | Pending | Nov 28, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialTokyo Women'S Medical University has 2 pending office actions as of November 2026, spread across 2 art units and 2 examiners.
Risa Takenaka has the most, with 1 of Tokyo Women'S Medical University's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.